Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Risk Reduction Behavior 1Hot Flashes 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Venlafaxine Hydrochloride 2Sodium Chloride 2Magnesium Oxide 2Gabapentin 2Bupivacaine 2fezolinetant 1black cohosh root extract 1bazedoxifene 1Tamoxifen 1Soybean Proteins 1Solifenacin Succinate 1Isoflavones 1Hypericum extract LI 160 1Estrogens, Conjugated (USP) 1Estetrol 1Daptomycin 1Clonidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hot Flashes × bazedoxifene × Clear all
NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡